Reliance Global Group, Inc. (RELI) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2024. Reliance Global Group, Inc. operates as a diversified insurance intermediary, focusing on acquiring wholesale and retail insurance agencies and developing insurtech platforms (5MinuteInsure.com and RELI Exchange). The company employs a "One-Firm" strategy to integrate acquired agencies. As of July 1, 2024, the company effectuated a 1-for-17 reverse stock split, and all share data in this report has been retroactively adjusted to reflect this split.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|
| Total Revenue | $3,233,342 | $7,315,780 | $7,135,008 |
| Net Loss | $(1,489,395) | $(6,836,057) | $(2,843,824) |
| Loss from Operations | $(1,146,578) | $(6,178,299) | $(2,843,111) |
| Adjusted EBITDA (Non-GAAP) | $(177,966) | $(251,620) | $(9,288) |
| Cash and Restricted Cash | $2,815,611 (as of June 30, 2024) | ||
| Working Capital | ~$600,000 (as of June 30, 2024) | ||
| Total Debt (Current + Long Term) | ~$11.76M (Gross Long-Term Debt) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 1% in Q2 and 3% YTD compared to 2023, driven by organic growth in commission income.
- Asset Impairment: A significant non-cash asset impairment charge of $3,922,110 was recorded in the first half of 2024 related to intangible assets from discontinued operations. This significantly impacted the YTD net loss.
- Operating Expenses: Total operating expenses decreased 13% in Q2 compared to the prior year, primarily due to the elimination of earn-out payable changes and reduced depreciation/amortization following asset impairments. However, YTD expenses increased 35% due to the impairment charge and higher acquisition/legal costs.
- Warrant Liabilities: The company recognized a gain of $60,667 in Q2 and $156,000 YTD from the change in fair value of warrant liabilities, contrasting with a loss of $1.59M in Q2 2023. All Series B and Series G warrants were exercised in Q2 2024, leaving minimal warrant liability outstanding.
- Equity Issuance: The company raised approximately $2.07 million through its At-The-Market (ATM) program during the first six months of 2024.
Guidance, Outlook, and Risks
- Acquisition Strategy: On May 14, 2024, the company entered into a Stock Exchange Agreement to acquire Spetner Associates for approximately $13.7 million (cash, stock, and promissory note). Spetner is a benefits enrollment company serving over 75,000 employees.
- Liquidity: Management believes current cash resources and the ability to raise capital via the ATM program are sufficient to meet obligations for the next 12 months. The remaining ATM capacity is approximately $1.73 million.
- Nasdaq Compliance: The company received notice from Nasdaq regarding failure to maintain the $1.00 minimum bid price requirement. The company regained compliance on July 16, 2024.
- Risks: Key risks include the competitive nature of the insurance brokerage industry, reliance on a few major insurance carriers (Priority Health accounted for 35% of YTD revenue), and the potential for future asset impairments.
Investor Verification Checklist
- Asset Impairment Details: Verify the specific intangible assets written off ($3.9M) and the impact on future amortization expenses.
- Spetner Acquisition Status: Confirm the closing date and final terms of the Spetner Associates acquisition.
- Debt Covenants: Review the terms of the Oak Street Funding LLC loans (totaling ~$11.76M) for any covenants related to liquidity or EBITDA that could be impacted by current losses.
- ATM Program Utilization: Monitor the remaining $1.73M ATM capacity and the average share price at which shares are being sold.
- Customer Concentration: Assess the risk associated with Priority Health representing 35% of YTD revenue.